Navigation Links
Custom Spine Announces Lew Bennett as President
Date:1/20/2009

PARSIPPANY, N.J., Jan. 20 /PRNewswire/ -- Custom Spine announced today that Lew Bennett has been named President and will serve on the Board of Directors. Mr. Bennett brings with him over 48 years experience in the medical device industry. Having retired and re-entered the market six times, Mr. Bennett's love of a new challenge and dedication to the medical device industry is clear. Custom Spine founder and CEO, Mahmoud Abdelgany commented, "We are really excited to have Lew Bennett taking the helm of Custom Spine. He brings to the company a deep knowledge of the market and a passion for success."

Mr. Bennett has held senior executive positions with several companies in the orthopedic and spine industry including: Executive Vice President, Officer, and Board Member of NuVasive, Inc.; early investor, Executive Vice President, Officer and Director of Sofamor Danek (now a division of Medtronic, Inc.); President, General Medical Division, Smith & Nephew, Inc. and President of Dillion Manufacturing. In addition, he was one of the founders of Howmedica Corporation (now Stryker Howmedica Osteonics). Prior to founding Howmedica, he was Regional Manager for Ethicon Corporation, a division of Johnson & Johnson. Mr. Bennett currently serves on the Boards of Directors for Custom Spine and HydroCision.

Mr. Bennett's proven success and love of developing people have afforded him the opportunity to be the guest speaker at numerous medical conferences and to lecture at over 300 orthopedic and neurological resident programs. He has consulted for over 550 orthopedic and neurological practices and universities.

Custom Spine develops advanced fixation and interbody systems with unique features that increase the ease of implantation for the surgeon and provide added benefits for the patient. When asked about Custom Spine products Mr. Bennett commented, "Custom Spine's engineers have developed innovative products and instrumentation that will provide great benefit to the surgeon and patient. I am excited to lead the team as we continue to pioneer new products for the spine industry."

About Custom Spine

Custom Spine, Inc. is a pioneering leader in the spine market creating the next generation of surgeon-friendly spinal implants and instruments that provide superior performance and patient care. The company was founded by top engineers and industry professionals in partnership with orthopedic and neurological spine surgeons to develop advanced medical solutions. Custom Spine (www.customspine.com) is a privately held company headquartered in Parsippany, New Jersey. For more information, please contact 1-973-808-0019.


'/>"/>
SOURCE Custom Spine
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
2. Customized virus kills brain tumor stem cells that drive lethal cancer
3. Whole Foods Market(R) Donates $25,000, for Midwest Farmers - Hoping to Match an Additional $10,000, via Customer Donations
4. Blue Cross Blue Shield of Michigan Offers New Approach to Customer Group Wellness
5. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
6. J.D. Power and Associates Reports: CIGNA HealthCare Recognized for Call Center Customer Satisfaction Excellence For a Second Consecutive Year
7. Nucletron Announces Management Buy-Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community
8. Texas Aviation Services: Over 20 Years of Creating Flying Emergency Rooms for Airborne EMS Customers in US and Latin America
9. LodgeNet Deploys Customized Kid Friendly Solution With Childrens Hospital of Pittsburgh of UPMC
10. New Technology at Unitrin Direct Gives Customers an Alternative to Waiting
11. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Charlevoix, MI (PRWEB) , ... February 24, 2017 ... ... venue in Charlevoix, once again hosted their Military Wedding Giveaway, with the ... be hosted by Castle Farms with services generously donated from local vendors: A ...
(Date:2/23/2017)... ... 23, 2017 , ... On February 22, 2017 the U.S. ... to withdraw previous guidance issued by the Obama Administration requiring schools to treat ... 2016 by the Obama Administration came in response to a growing number of ...
(Date:2/23/2017)... ... 2017 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... Beach to host its Swirl: Miami Wine Tasting Event on March 28, 2017. ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is pleased ... KLS is a longtime supporter of the event. , "We are pleased that KLS ... Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track record of ...
(Date:2/23/2017)... Hollywood, CA (PRWEB) , ... February 23, 2017 , ... ... pleased to announce that they are sponsoring a raffle. Throughout the month of February, ... Winners will receive a gift card for a dinner for two at the Cheesecake ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Feb. 24, 2017 Juan Monteverde , ... PC , a boutique securities firm headquartered at the ... , announces that a class action lawsuit has ...  against Inotek Pharmaceuticals Corporation (NASDAQ:  ITEK)("Inotek" or ... securities between July 23, 2015 and December 30, 2016, inclusive ...
(Date:2/24/2017)... -- Directors from Pharma To Market Pty Ltd and Ador Consulting Pte ... the founding of Pharma To Market Pte Ltd, based in ... to announce their expansion into Asia with ... The company are delighted to appoint Joelle Chia , former ... based entity. Joelle brings with her an extensive business ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an ... that it has acquired exclusive worldwide rights to ... innovative HDAC inhibitor targeting hematological and solid tumors. ... Phase 1 and 2 clinical trials of Abexinostat ... have already been completed, demonstrating that Abexinostat ...
Breaking Medicine Technology: